Wealth Enhancement Advisory Services’s Integra LifeSciences IART Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$319K	Buy	23,797 +2,874	+14%	+$49.6K	﹤0.01%	3285
2026 Q2	$393K	Buy	+20,923	New	+$293K	﹤0.01%	2931
2026 Q1	–	Sell	-13,497	Closed	-$177K	–	3731
2025 Q4	$177K	Sell	13,497 -703	-5%	-$9.35K	﹤0.01%	3311
2025 Q3	$205K	Buy	14,200 +848	+6%	+$11.6K	﹤0.01%	3126
2025 Q2	$180K	Buy	13,352 +1,927	+17%	+$28K	﹤0.01%	3020
2025 Q1	$251K	Buy	+11,425	New	+$269K	﹤0.01%	2580
2024 Q3	–	Sell	-12,929	Closed	-$377K	–	2858
2024 Q2	$377K	Buy	12,929 +2,560	+25%	+$75.9K	﹤0.01%	1827
2024 Q1	$368K	Buy	10,369 +163	+2%	+$6.52K	﹤0.01%	1780
2023 Q4	$444K	Buy	10,206 +2,671	+35%	+$105K	﹤0.01%	1581
2023 Q3	$288K	Buy	+7,535	New	+$317K	﹤0.01%	1768

Other funds holding IART

Access Investment Management Atlanta, Georgia $412M AUM 14.18% 1-Year Est. Return

Leeward Investments Boston, Massachusetts $1.98B AUM 28.98% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Choreo LLC Rockford, Illinois $9.7B AUM 18.43% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

Wealth Enhancement Advisory Services's IART Position: Q3 2026 in Review

Wealth Enhancement Advisory Services increased its Integra LifeSciences (IART) stake by 14% in Q3 2026, buying an estimated $49.6K and bringing the position to 23,797 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #3285.

Wealth Enhancement Advisory Services first reported a position in IART in Q3 2023 and has held it in 10 quarters since. The position peaked at $444K in Q4 2023. 40 funds tracked by Wall St. Rank hold IART as of Q3 2026.

Wealth Enhancement Advisory Services held 23,797 shares of Integra LifeSciences worth $319K as of Q3 2026.
Wealth Enhancement Advisory Services bought 2,874 Integra LifeSciences shares in Q3 2026, an estimated $49.6K.
Integra LifeSciences made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q3 2026, its #3285 holding.
Wealth Enhancement Advisory Services first reported a position in Integra LifeSciences in Q3 2023 and has held it in 10 quarters since.
Wealth Enhancement Advisory Services's Integra LifeSciences position peaked at $444K in Q4 2023.
40 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.